Company Filing History:
Years Active: 1999-2006
Title: Peter Steinlein: Innovator in Immunomodulation and Hematopoietic Cell Cultivation
Introduction
Peter Steinlein is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of immunology and cell biology, holding a total of 2 patents. His work focuses on developing pharmaceutical compositions that enhance immunomodulatory activities.
Latest Patents
Steinlein's latest patents include a pharmaceutical composition for immunomodulation based on peptides and adjuvants. This composition contains at least one peptide or protein fragment with immunomodulatory activity, combined with an adjuvant. The peptide is derived from a pathogenic agent or a tumor antigen, while the adjuvant enhances the binding of the peptide to the cells of the individual being treated. This innovative approach aims to strengthen the immunomodulatory activity of the peptide, making it particularly useful as a vaccine, such as a tumor vaccine. Another patent focuses on the process for preparing and cultivating hematopoietic progenitor cells, which is crucial for advancements in regenerative medicine.
Career Highlights
Peter Steinlein is currently associated with Boehringer Ingelheim International GmbH, where he continues to push the boundaries of pharmaceutical research. His work has been instrumental in developing new therapeutic strategies that leverage the immune system's capabilities.
Collaborations
Steinlein has collaborated with esteemed colleagues such as Hartmut Beug and Oliver Wessely, contributing to a rich environment of innovation and research.
Conclusion
Peter Steinlein's contributions to immunology and cell biology exemplify the impact of innovative thinking in the pharmaceutical industry. His patents reflect a commitment to advancing medical science and improving patient outcomes.